Try our Advanced Search for more refined results
Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al
Case Number:
2:22-cv-00223
Court:
Nature of Suit:
Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- American Center for Law & Justice Inc.
- Bustos Law Firm PC
- Covington & Burling
- Debevoise & Plimpton
- Faegre Drinker
- Fillmore Law Firm
- Hogan Lovells
- McCarn & Weir
- Morgan Williamson
- Mullin Hoard
- Perdue Brandon
- Samples Jennings
- Sheppard Mullin
- Shutts & Bowen
- Smith Appellate Law Firm
- Weycer Kaplan
Companies
- American Academy of Family Physicians
- American Medical Association Inc.
- Charlotte Lozier Institute
- Judicial Watch Inc.
Government Agencies
- Commonwealth of Kentucky
- Food and Drug Administration
- State of Indiana
- State of Tennessee
- U.S. Department of Health and Human Services
Sectors & Industries:
-
December 10, 2024
United Health Denials, Patent Antitrust Fight And Neb. Pot Law
United Healthcare must take a third look at its coverage denial for a patient's mental health and substance abuse treatment, and a former state senator asked the Nebraska Court of Appeals to wade into his fight against medical marijuana legalization. Here, Law360 Healthcare Authority looks at the significant cases and decisions that shaped the industry over the last week.
-
December 06, 2024
Biden Admin Says Abortion Drug Fight Can't Stay In Texas
The Biden administration and mifepristone-maker Danco Laboratories LLC doubled down Friday on their bids to end the litigation challenging federal approvals for the abortion medication, arguing the three intervening states can't continue to litigate in Texas federal court now that the private plaintiffs have dropped their claims.
-
November 20, 2024
3 States To Challenge Abortion Regs After Docs Drop Claims
Anti-abortion medical groups that were dealt a loss by the U.S. Supreme Court earlier this year have now dropped out of their lawsuit challenging federal approvals for mifepristone, leaving Missouri, Idaho and Kansas to carry on litigation over the abortion medication.
-
January 23, 2024
3 States Ask To Join High Court Case Against Abortion Drug
Republican attorneys general in Missouri, Idaho and Kansas moved to join the case in the U.S. Supreme Court challenging federal approvals for the abortion medication mifepristone, asking the justices to ensure the challenge isn't dismissed for lack of standing.
-
January 12, 2024
Judge OKs Bid By 3 States To Join Suit Against Abortion Drug
A Texas federal judge granted permission Friday for Missouri, Kansas and Idaho to join a lawsuit challenging federal approvals for the abortion medication mifepristone, ruling that the states have unique interests that aren't represented by others in the case.
-
December 18, 2023
Feds Say 3 States Can't Intervene In Abortion Pill Suit
The federal government asked a Texas court to reject a motion for intervention in a dispute over the abortion drug mifepristone, arguing that there was no point in adding Missouri, Idaho and Kansas to the suit when the original plaintiffs who sued lacked sufficient standing.
-
November 17, 2023
Judge Won't Delay Ruling If States Can Join Abortion Pill Suit
A Texas federal judge told the government to make its argument about why Missouri, Kansas and Idaho shouldn't intervene in a lawsuit over various rulings about the abortion drug mifepristone, saying that there's no need to wait for the U.S. Supreme Court to decide if it will review the case.
-
November 15, 2023
3 States Slam Feds' Request For Pause In Abortion Drug Suit
Missouri, Kansas and Idaho want a Texas federal judge to decide now whether they can join a lawsuit against the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services over the abortion drug mifepristone, instead of waiting to see if the U.S. Supreme Court weighs in on a Fifth Circuit ruling that would limit access to the drug.
-
November 06, 2023
3 States Ask To Join Suit To Halt Access To Abortion Drug
Missouri, Kansas and Idaho have asked to join a lawsuit against the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services over the abortion drug mifepristone, with the states arguing they have special claims and rights to protect in the case.
-
April 12, 2023
Abortion Pill Battle Puts Squeeze On Drug Benefit Managers
A Texas federal court's recent decision upending certification of a pill used to terminate pregnancies will put pressure on the pharmacy benefit managers that act as intermediaries between drugmakers and insurers, attorneys say, heightening PBMs' potential legal exposure at the same time that states are seeking to ramp up regulations.